推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33363733,021-34612310

chinasupport@letpub.com

登录 注册 新注册优惠

Recent Patents on Anti-Cancer Drug Discovery

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 RECENT PAT ANTI最新评论:去年9月底投的稿,到录用为止应该算是3-4个月,主要是我在拟接收后因为一些格式问题浪费了近1个月的时间。应该是比较容易录用的... (2024-08-27)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Recent Patents on Anti-Cancer Drug Discovery期刊基本信息Hello,您是该期刊的第23748位访客


基本信息 登录收藏
期刊名字Recent Patents on Anti-Cancer Drug DiscoveryRecent Patents on Anti-Cancer Drug Discovery

RECENT PAT ANTI-CANC
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.2
51人评分
我要评分

声誉
6.4

影响力
3.9

速度
7.0

期刊ISSN1574-8928
微信扫码收藏此期刊
E-ISSN2212-3970
2023-2024最新影响因子
(数据来源于搜索引擎)
2.5 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:2.432
2023-2024自引率4.00%点击查看自引率趋势图
五年影响因子2.6
JCI期刊引文指标 0.5
h-index 36
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
4.500.5400.442
学科分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q2111 / 272
大类:Medicine
小类:Oncology
Q2183 / 404
大类:Medicine
小类:Drug Discovery
Q386 / 157
大类:Medicine
小类:Cancer Research
Q3139 / 230

期刊简介
Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.
期刊官方网站http://www.recentpatentsonanticancerdrugdiscovery.com/
期刊投稿网址http://bsp-cms.eurekaselect.com/index.php/PRA/login?source=%2Findex.php%2FPRA
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Recent Patents on Anti-Cancer Drug Discovery的语言要求,还能让Recent Patents on Anti-Cancer Drug Discovery编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Recent Patents on Anti-Cancer Drug Discovery编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
出版商Bentham Science Publishers B.V.
涉及的研究方向医学-药学
出版国家或地区U ARAB EMIRATES
出版语言English
出版周期Tri-annual
出版年份2006
年文章数 38点击查看年文章数趋势图
Gold OA文章占比0.00%
研究类文章占比:
文章 ÷(文章 + 综述)
42.11%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ3183/322
学科:PHARMACOLOGY & PHARMACYSCIEQ3180/354
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ3208/322
学科:PHARMACOLOGY & PHARMACYSCIEQ3236/354
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区4区3区
ONCOLOGY
肿瘤学
1区1区4区
PHARMACOLOGY & PHARMACY
药学
2区2区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 4区4区3区
ONCOLOGY
肿瘤学
4区1区4区
PHARMACOLOGY & PHARMACY
药学
2区3区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区4区2区
ONCOLOGY
肿瘤学
4区4区4区
PHARMACOLOGY & PHARMACY
药学
4区4区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-8928%5BISSN%5D
平均审稿速度网友分享经验:
平均3.0个月
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Recent Patents on Anti-Cancer Drug Discovery顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Recent Patents on Anti-Cancer Drug Discovery期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Recent Patents on Anti-Cancer Drug Discovery中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Recent Patents on Anti-Cancer Drug Discovery上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    PHARMACOLOGICAL REVIEWS21034.70
    DRUG RESISTANCE UPDATES10026.20
    ADVANCED DRUG DELIVERY REVIEWS27828.10
    TRENDS IN PHARMACOLOGICAL SCIENCES20123.90
    PHARMACOLOGY & THERAPEUTICS18023.00
    MEDICINAL RESEARCH REVIEWS11929.30
    PHARMACOLOGICAL RESEARCH11818.70
    ARCHIVES OF PHARMACAL RESEARCH7513.40
    BIOMEDICINE & PHARMACOTHERAPY7811.90
    BRITISH JOURNAL OF PHARMACOLOGY19015.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE659210
    BIOMATERIALS554820
    BIOMEDICINE & PHARMACOTHERAPY532714
    Frontiers in Pharmacology500779
    Journal of Materials Chemistry B492399
    Frontiers in Immunology476594
    COMPUTERS IN BIOLOGY AND MEDICINE453013
    JOURNAL OF ETHNOPHARMACOLOGY451629
    COLLOIDS AND SURFACES B-BIOINTERFACES430673
    Frontiers in Oncology424672
  •  

    Recent Patents on Anti-Cancer Drug Discovery Recent Patents on Anti-Cancer Drug Discovery
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.High-throughput Strategy Accelerates the Progress of Marine Anticancer Peptide Drug Development.

    Author: Lyu P1, Kwok HF1.
    Journal: Recent Pat Anticancer Drug Discov. 2019;14(1):2-4. doi: 10.2174/1574892813999181114152127.
        PubMed      DOI
    2.Chimeric Antigen Receptor T Cell Immunotherapy for Tumor: A Review of Patent Literatures

    Author: Fu M1, Tang L1.
    Journal: Recent Pat Anticancer Drug Discov. 2019;14(1):60-69. doi: 10.2174/1574892814666190111120908.
        PubMed      DOI
    3.From Antimicrobial to Anticancer Peptides: The Transformation of Peptides.

    Author: Qin Y1,2, Qin ZD1, Chen J3, Cai CG4, Li L1, Feng LY1, Wang Z1, Duns GJ1, He NY2, Chen ZS5, Luo XF1.
    Journal: Recent Pat Anticancer Drug Discov. 2019;14(1):70-84. doi: 10.2174/1574892814666190119165157.
        PubMed      DOI
    4.Enzyme and Transporter Kinetics for CPT-11 (Irinotecan) and SN-38: An Insight on Tumor Tissue Compartment Pharmacokinetics Using PBPK.

    Author: Fan Y1,2, Mansoor N3, Ahmad T4, Wu ZX2, Khan RA3, Czejka M5, Sharib S4, Ahmed M6, Chen ZS2, Yang DH2.
    Journal: Recent Pat Anticancer Drug Discov. 2019 Feb 12. doi: 10.2174/1574892814666190212164356. [Epub ahead of print]
        PubMed      DOI
    5.Inhibitory effect of hydroxysafflower yellow B on the proliferation of human breast cancer MCF-7 cells.

    Author: Qu C1, Zhu W1, Dong K2, Pan Z1, Chen Y1, Chen X1, Liu X1, Xu W1, Lin H1, Zheng Q1, Li D1.
    Journal: Recent Pat Anticancer Drug Discov. 2019 May 15. doi: 10.2174/1574891X14666190516102218. [Epub ahead of print]
        PubMed      DOI
    6.Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process.

    Author: Zhang K, Yang G, Wu W, Zhang J, Xia X, Jiang T, Cao J, Huang K, Qiu Z, Huang C.
    Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):236-44.
        PubMed  
    7.Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.

    Author: Huang L, He R, Luo W, Zhu YS, Li J, Tan T, Zhang X, Hu Z, Luo D.
    Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):184-96.
        PubMed  
    8.Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy.

    Author: Fang XN, Fu LW.
    Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):141-51.
        PubMed  
    9.Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells.

    Author: Wang Y, Ma J, Yan X, Chen X, Si L, Liu Y, Han J, Hao W, Zheng Q.
    Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):215-27.
        PubMed  
    10.Application of nanotechnology in the diagnosis and therapy of hepatocellular carcinoma.

    Author: Hou XY, Jiang G, Yang CS, Tang JQ, Wei ZP, Liu YQ.
    Journal: Recent Pat Anticancer Drug Discov. 2016 Mar 9. [Epub ahead of print]
        PubMed  
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Energy Material Advances013.80
    Journal of High Energy Astrophysics119.70
    VIEW012.60
    HARVARD BUSINESS REVIEW01.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.90
    ACM Transactions on Intelligent Systems and Technology469.30
    Journal of the American Nutrition Association02.50
    TRANSACTIONS OF TIANJIN UNIVERSITY012.50
    Machine Intelligence Research06.70
    Molecular Biomedicine06.30
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共16


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室